跳至主要内容
临床试验/JPRN-jRCTs052190078
JPRN-jRCTs052190078已完成3 期

se of pneumatic needle-free hyaluronic acid injection technology for correction of atrophic facial acne scars in adult patients: a randomized placebo-controlled split-face comparative phase 3 study - pneumatic needle-free injection technology trial

Yuki Yamamoto0 个研究点目标入组 30 人开始时间: 2019年12月5日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

The findings of this study suggest that PA-HA treatment is effective against all severity rolling type atrophic facial acne scars in Japanese subjects and has minimal AEs.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 < 65age old(—)
性别
All

入选标准

  • Male or female 25-65 years old. Presence of more than 4 distensible facial moderate to severe atrophic acne scars.

排除标准

  • Patient with having severe underlying disease, pregnancy or lactation, Porphyria, cardiac conduction disturbance, allergic conditioned, local anesthesia allergies and hyaluronic acid produced allergies previously, vascular or bleeding disorders, treated with anticoagulant therapy, autoimmune disease, treated with immunosuppressive therapy, keloid scar formation, hypertrophic scar formation, malignant skin tumor, pigment anomaly, inflammatory disease that a symptom may aggravate in irritation by a treatment, medical history of herpesvirus infection. Invasive aesthetic treatments or facial surgery within 6 months prior to the study enrollment.
  • Physical or chemical aesthetic treatments within 3 month prior to the study enrollment. Clinically significant acne in the proposed treatment areas defined as more than 3 active inflammatory acne lesions in the treatment areas.

研究者

发起方
Yuki Yamamoto

相似试验

se of pneumatic needle-free hyaluronic acid... | 临床试验